Sugi Predict

Sugi Predict / Targets / MYL6

MYL6

Myosin light polypeptide 6 · P60660 · MYL6 on Sugi Atlas →

0 patent compounds predicted against MYL6, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MYL6 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Beta Blockade on Left Ventricular Remodeling and Function in Moderate to Severe Asymptomatic Aortic Regurgitation PHASE4COMPLETED
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem PHASE2/PHASE3COMPLETED
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure PHASE2COMPLETED
Biologic Correlative Taxotere/AC PHASE2COMPLETED
Evaluating MED2005 & Nitrostat Bioavailability PHASE1COMPLETED
Transcutaneous Functional Magnetic Muscle Stimulation in Critically Ill nanUNKNOWN
Genetic Analysis of African-Americans With High Blood Pressure nanCOMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium nanCOMPLETED
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Influence of Sarcopenia on the Course of the Diseases nanRECRUITING
Molecular and Genetic Studies of Congenital Myopathies nanRECRUITING
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms nanCOMPLETED
Phenotypic and Genotypic Identification and Characterization of MYH9-related Constitutional Thrombocytopenia nanCOMPLETED
High-definition Surface Electromyography Markers for the Diagnosis of Sarcopenia nanRECRUITING
Evaluation of Albuminuria HIV-Infected Patients nanCOMPLETED
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development nanCOMPLETED
Exploring Novel Biomarkers of ICU-AW in Mechanically Ventilated Children at the Molecular Level nanENROLLING_BY_INVITATION
Genetic Determinants of Exercise-Induced Muscle Damage (POLYGENDOMUS) nanRECRUITING
Congenital Muscle Disease Study of Patient and Family Reported Medical Information nanRECRUITING
Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation nanCOMPLETED
Evaluation of the Regeneration Capacity of Satellite Cells From the Quadriceps Compared to That of the Diaphragm nanCOMPLETED
3D-Microscopic Muscle Architecture in Cerebral Palsy nanRECRUITING
Improvement of DIAgnostic and Phenotype-genotype Correlation Studies in Patients With MYOpathy Suspected of TITinopathy nanUNKNOWN
Chronic Muscle Disuse in the Elderly nanCOMPLETED
Recurrent Acute Myocarditis Registry nanUNKNOWN
Characteristics of Nondystrophic Myotonias nanCOMPLETED
High-definition Surface Electromyography Markers for the Diagnosis and Monitoring of Sarcopenia nanRECRUITING
The Natural History and Muscle Fatigability of Patients With Congenital Myopathies. nanRECRUITING
Effect of Exercise on the Human Skeletal Muscle Phosphoproteome nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a MYL6 binder may also engage these)

ProteinNameSimilarity
P60662 — 1.000 P60662 →
P60661 — 1.000 P60661 →
Q60605 — 1.000 Q60605 →
Q5R844 — 1.000 Q5R844 →
Q64119 — 0.998 Q64119 →
P02607 — 0.995 P02607 →
Q91WQ9 — 0.938 Q91WQ9 →
DCUN1D1 DCN1-like protein 1 0.938 landscape →
Q5ZKU1 — 0.938 Q5ZKU1 →
Q3T0E8 — 0.937 Q3T0E8 →
Q9QZ73 — 0.935 Q9QZ73 →
Q6P069 — 0.927 Q6P069 →
Q8BZJ7 — 0.927 Q8BZJ7 →
P05044 — 0.927 P05044 →
DCUN1D2 DCN1-like protein 2 0.925 landscape →
Q9CQ46 — 0.922 Q9CQ46 →
C7A278 — 0.922 C7A278 →
Q60960 — 0.921 Q60960 →
Q1W374 — 0.920 Q1W374 →
Q3MHE4 — 0.920 Q3MHE4 →
B1H2N3 — 0.920 B1H2N3 →
A2VE08 — 0.919 A2VE08 →
Q259G4 — 0.918 Q259G4 →
Q7XPW5 — 0.918 Q7XPW5 →
Q5R909 — 0.918 Q5R909 →
P83953 — 0.918 P83953 →
O70133 — 0.917 O70133 →
STK39 STE20/SPS1-related proline-alanine-rich protein kinase 0.916 landscape →
KPNA1 Importin subunit alpha-5 0.916 landscape →
P16905 — 0.916 P16905 →